Alan Auerbach is President and Chief Executive Officer of Puma Biotechnology, Inc. (PBYI). The company reported total compensation of $3,062,337 for fiscal year 2025.
| Salary | $931,333 |
|---|---|
| Bonus | — |
| Stock awards | $551,549 |
| Option awards | $535,513 |
| Non-equity incentive plan | $1,027,307 |
| Pension and non-qualified deferred compensation | — |
| All other compensation | $16,635 |
| Total | $3,062,337 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Puma Biotechnology, Inc. filed April 28, 2026, accession 0001437749-26-013671.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $931,333 | — | $551,549 | $535,513 | $1,027,307 | — | $16,635 | $3,062,337 |
| FY2024 | President and Chief Executive Officer | $904,207 | $0 | $1,055,548 | $1,055,354 | $938,612 | $0 | $16,210 | $3,969,931 |
| FY2023 | President and Chief Executive Officer | $877,871 | $0 | $818,309 | $821,842 | $407,991 | $0 | $18,735 | $2,944,748 |
Totals as disclosed in each year's own compensation disclosure for Puma Biotechnology, Inc..
| Peer-group chief executive median | $3,445,941 |
|---|---|
| Difference from that median | $-383,604 |
| Percentile within the disclosed peer group | 40th |
| Peers with a disclosed figure | 10 |
Medians and percentiles are computed across the peer group Puma Biotechnology, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Alan Auerbach this page | President and Chief Executive Officer | $3,062,337 |
| Jeff Ludwig | Chief Commercial Officer | $1,476,167 |
| Maximo Nougues | Chief Financial Officer | $1,241,215 |
| Douglas Hunt | Chief Regulatory Affairs, Medical Affairs, and Pharmacovigilance Officer | $1,061,400 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Puma Biotechnology, Inc. compensation brief.
Alan Auerbach's compensation sits inside Puma Biotechnology, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.